These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3065364)

  • 1. Pharmacological treatments of tardive dyskinesia in the 1980s.
    Jeste DV; Lohr JB; Clark K; Wyatt RJ
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):38S-48S. PubMed ID: 3065364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL; Piccirilli M; Rizzo PA
    Riv Neurol; 1984; 54(3):199-215. PubMed ID: 6147888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In search of treatment for tardive dyskinesia: review of the literature.
    Jeste DV; Wyatt RJ
    Schizophr Bull; 1979; 5(2):251-93. PubMed ID: 37597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncatecholaminergic treatments of tardive dyskinesia.
    Alphs L; Davis JM
    J Clin Psychopharmacol; 1982 Dec; 2(6):380-5. PubMed ID: 6129267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA; Gautier J
    Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
    Jeste DV; Wyatt RJ
    Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia: recognition, management, and prevention.
    Crews EL
    Ala J Med Sci; 1980 Apr; 17(2):165-8. PubMed ID: 7416430
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of tardive dyskinesia: current update.
    Simpson GM; Pi EH; Sramek JJ
    Drugs; 1982 May; 23(5):381-93. PubMed ID: 7047137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The electrophysiological approach to tardive dyskinesias].
    Rondot P
    Encephale; 1988 Sep; 14 Spec No():183-9. PubMed ID: 2905645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic studies of tardive dyskinesia.
    Chase TN; Tamminga CA
    Adv Biochem Psychopharmacol; 1980; 24():457-61. PubMed ID: 7405673
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinergic treatments for tardive dyskinesia.
    Alphs LD; Davis JM
    Mod Probl Pharmacopsychiatry; 1983; 21():168-86. PubMed ID: 6140629
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopaminergic and GABAergic aspects of tardive dyskinesia [proceedings].
    Casey DE; Gerlach J; Magelund G; Christensen TR
    Psychopharmacol Bull; 1981 Jan; 17(1):49-50. PubMed ID: 7232658
    [No Abstract]   [Full Text] [Related]  

  • 16. Tardive dyskinesia: a review and current treatment options.
    Najib J
    Am J Ther; 1999 Jan; 6(1):51-60. PubMed ID: 10423647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABAmimetic treatments for tardive dyskinesia: efficacy and mechanism.
    Tamminga CA; Thaker GK; Nguyen JA
    Psychopharmacol Bull; 1989; 25(1):43-6. PubMed ID: 2672071
    [No Abstract]   [Full Text] [Related]  

  • 18. Animal models of tardive dyskinesia--a review.
    Kulkarni SK; Naidu PS
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
    Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE
    J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.